Ultrasound Gastroscopes Market Size, Share, Growth, and Industry Analysis, By Type (Optic Ultrasound Gastroscope,Linear Array Ultrasound GastroscopeS), By Application (Hospital,Clinic,Medical Center,Others), Regional Insights and Forecast to 2035

Ultrasound Gastroscopes Market Overview

The global Ultrasound Gastroscopes Market size is projected to grow from USD 709.5 million in 2026 to USD 737.17 million in 2027, reaching USD 1001.08 million by 2035, expanding at a CAGR of 3.9% during the forecast period.

The ultrasound gastroscopes market is witnessing significant technological advancement, with over 2,500 units deployed globally across diagnostic and therapeutic gastroenterology centers in 2024. Demand is driven by increasing gastrointestinal cancer screenings, with over 4.5 million upper GI endoscopies performed annually worldwide.

In 2024, more than 62% of hospitals in developed economies integrated ultrasound gastroscopes into routine diagnostic workflows. Growing adoption is linked to their ability to combine high-resolution ultrasound with endoscopic visualization, allowing improved tumor staging accuracy by over 78% compared to traditional methods. The market outlook indicates steady growth, supported by increasing healthcare infrastructure investments in Asia-Pacific and North America.

The future scope is promising, with AI-assisted imaging integration projected to cover over 45% of diagnostic ultrasound gastroscope units by 2030. Advancements in miniaturized ultrasound transducers and flexible insertion tubes are expected to reduce procedure times by up to 25%, enhancing patient throughput and clinical efficiency, especially in high-volume tertiary care hospitals.

The USA ultrasound gastroscopes market accounted for more than 38% of global demand in 2024, driven by over 1.2 million annual upper gastrointestinal diagnostic procedures. With 6,000+ gastroenterologists actively using endoscopic ultrasound (EUS) systems, adoption rates in U.S. hospitals have surpassed 70% in urban medical centers. The increasing prevalence of esophageal and pancreatic cancers, affecting over 90,000 new patients annually, is a key driver. Furthermore, FDA approvals for advanced imaging features have accelerated clinical acceptance, with over 500 facilities upgrading to next-generation ultrasound gastroscopes between 2023 and 2024.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 64% growth in adoption due to rising GI cancer screening demand worldwide in 2024.
• Major Market Restraint: 42% of facilities report high equipment maintenance costs impacting operational efficiency globally.
• Emerging Trends: 58% increase in AI-assisted ultrasound gastroscope integration across major global healthcare facilities.
• Regional Leadership: 39% global share held by North America in 2024 with strong hospital infrastructure.
• Competitive Landscape: 47% of sales concentrated among top three manufacturers dominating worldwide market presence.
• Market Segmentation: 53% share dominated by linear array ultrasound gastroscopes across multiple medical applications.
• Recent Development: 36% of new launches focus on miniaturized probe technology improving diagnostic imaging accuracy.

Ultrasound Gastroscopes Market Trends

The ultrasound gastroscopes market is evolving with a strong emphasis on precision diagnostics, minimally invasive procedures, and AI-enhanced imaging capabilities. In 2024, over 72% of newly procured hospital endoscopy units in developed countries incorporated ultrasound gastroscope functionality, enabling dual-mode imaging for enhanced clinical decisions. Globally, there were more than 5 million upper GI ultrasound-assisted procedures performed, with Asia-Pacific accounting for 41% of total cases. Hospitals are increasingly investing in hybrid endoscopy suites, with a 55% year-over-year rise in installation of integrated ultrasound platforms.

Ultrasound Gastroscopes Market Dynamics

The ultrasound gastroscopes market is shaped by growing clinical demand, advancing technology, and expanding healthcare infrastructure. In 2024, more than 68% of tertiary care hospitals globally had access to EUS technology, compared to 52% in 2019. This growth is largely driven by increasing detection rates of GI cancers, which rose by 15% over the last five years. Enhanced image clarity and lesion detection accuracy reported at over 90% are prompting wider adoption. However, challenges remain, with high acquisition costs limiting accessibility in low-income regions.

DRIVER

"Increasing global incidence of gastrointestinal cancers is propelling ultrasound gastroscope adoption."

In 2024, gastrointestinal cancers accounted for over 4.8 million new cases globally, creating a surge in demand for advanced diagnostic tools. Ultrasound gastroscopes have shown a 78% improvement in tumor staging accuracy compared to conventional methods, making them indispensable for oncological assessment. Hospitals report a 25% reduction in diagnostic errors with EUS integration, directly influencing patient survival rates. With more than 2,000 new gastroenterology facilities opening in Asia-Pacific alone in the last three years, infrastructure readiness is supporting market penetration.

RESTRAINT

"High equipment acquisition and maintenance costs are limiting market penetration in resource-limited regions."

An advanced ultrasound gastroscope system can cost upwards of USD 150,000, with annual maintenance expenses exceeding USD 15,000 for high-volume facilities. In 2024, 42% of healthcare providers in low-income economies reported difficulty in accessing financing for such equipment. Downtime due to complex repairs can reach up to 12% annually, impacting patient scheduling. Additionally, the need for specialized training requiring an average of 120 operational hours adds to operational costs.

OPPORTUNITY

"Technological advancements in AI integration and miniaturized ultrasound probes are creating new market segments."

By 2030, AI-assisted lesion detection in ultrasound gastroscopes is projected to be used in over 45% of diagnostic units. Miniaturized transducers reduced in diameter by 18% since 2022 are enabling use in pediatric and complex anatomical cases previously unsuitable for standard devices. Over 30 companies are actively developing cloud-based imaging analytics platforms for remote second opinions, broadening applications in telehealth.

CHALLENGE

"Shortage of skilled operators and specialized training programs is slowing adoption in certain regions."

In 2024, less than 35% of gastroenterologists in Africa and Southeast Asia were trained in endoscopic ultrasound procedures. The average training period for proficiency in EUS can range from 6 to 12 months, with hands-on exposure to at least 150 cases recommended by leading medical associations. This lack of expertise limits clinical capacity despite available equipment. Additionally, competition for trained staff between private and public sectors has led to wage disparities of up to 40%, further affecting retention.

Ultrasound Gastroscopes Market Segmentation

The ultrasound gastroscopes market is segmented by type, application, and region, with demand patterns influenced by technological preference, clinical workload, and healthcare infrastructure. In 2024, linear array ultrasound gastroscopes accounted for 53% of global unit sales, driven by their superior image resolution and tumor staging accuracy. Optic ultrasound gastroscopes made up the remaining 47%, valued for their cost-effectiveness in medium-volume facilities. By application, hospitals dominate with over 61% usage share, followed by clinics at 25% and medical centers at 14%. This segmentation reflects patient flow, procedural complexity, and procurement budgets.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Optic Ultrasound Gastroscope: Optic ultrasound gastroscopes remain popular in cost-sensitive markets, accounting for 47% of total units sold in 2024. They offer adequate resolution for standard diagnostic work, with image clarity improvements of 22% since 2021 due to upgraded optics. These systems are commonly used in routine gastrointestinal screening and have an average lifespan of 7 years. Adoption is particularly strong in emerging economies, where 58% of hospitals prefer optic models over linear array alternatives.

The Optic Ultrasound Gastroscope segment is valued at USD 1.2 billion, representing 55% market share, with a CAGR of 6.5%, driven by increasing prevalence of gastrointestinal disorders, rising adoption of minimally invasive diagnostic procedures, and growing investments in advanced endoscopy devices globally.

Top 5 Major Dominant Countries in the Optic Ultrasound Gastroscope Segment

• United States: The U.S. leads the Optic Ultrasound Gastroscope market with USD 0.4 billion, capturing 18% share, and a CAGR of 6.7%, driven by high hospital adoption rates, increasing awareness of minimally invasive diagnostic solutions, and rapid technological advancements in endoscopic imaging systems.
• Germany: Germany holds USD 0.2 billion, representing 9% share, with a CAGR of 6.4%, fueled by expanding healthcare infrastructure, increasing number of gastroenterology procedures, high adoption of advanced medical devices, and strong investments in research and development in the optics-based gastroscopy segment.
• Japan: Japan contributes USD 0.15 billion, capturing 7% share, with a CAGR of 6.3%, supported by growing geriatric population, rising gastrointestinal disorder prevalence, increasing number of hospitals equipped with advanced endoscopy systems, and strong regulatory support for modern diagnostic technologies.
• China: China accounts for USD 0.12 billion, representing 5.5% share, with a CAGR of 6.6%, driven by the rising number of specialty hospitals, increasing awareness about early diagnosis of gastrointestinal diseases, government healthcare initiatives, and growing investments in high-end optical ultrasound gastroscope devices.
• France: France holds USD 0.1 billion, capturing 5% share, with a CAGR of 6.2%, fueled by expanding hospital networks, increasing gastrointestinal patient base, rising adoption of advanced diagnostic endoscopy tools, and growing focus on minimally invasive procedures for early disease detection.

Linear Array Ultrasound Gastroscope: Linear array ultrasound gastroscopes dominate high-end clinical segments, holding a 53% share in 2024. They provide enhanced Doppler imaging capabilities, with a 35% improvement in vascular assessment accuracy compared to radial or optic systems. Their role is critical in staging pancreatic, esophageal, and gastric cancers, enabling precise needle guidance for fine-needle aspiration (FNA) procedures. More than 70% of oncology-specialized hospitals in developed economies exclusively use linear array models. The integration of AI-assisted lesion recognition adopted in 31% of units by 2024 further strengthens their diagnostic value.

The Linear Array Ultrasound Gastroscope segment is valued at USD 1 billion, representing 45% market share, with a CAGR of 6.7%, propelled by increasing demand for high-resolution imaging, rising prevalence of GI cancers, and preference for precise interventional endoscopic procedures.

Top 5 Major Dominant Countries in the Linear Array Ultrasound Gastroscope Segment

• United States: The U.S. dominates this segment with USD 0.35 billion, representing 16% share, and a CAGR of 6.8%, driven by the high number of hospitals adopting linear array gastroscopes, technological advancements, and increasing focus on minimally invasive procedures for gastrointestinal and pancreatic diseases.
• Germany: Germany holds USD 0.18 billion, capturing 8% share, with a CAGR of 6.5%, fueled by strong healthcare infrastructure, rising gastrointestinal patient population, high adoption of advanced imaging technologies, and growing investments in interventional endoscopy procedures.
• Japan: Japan contributes USD 0.14 billion, representing 6.5% share, with a CAGR of 6.4%, supported by increasing prevalence of GI cancers, high geriatric population, widespread adoption of linear array gastroscopes in medical centers, and government initiatives promoting advanced healthcare technologies.
• China: China accounts for USD 0.11 billion, representing 5% share, with a CAGR of 6.7%, driven by growing urban healthcare facilities, rising demand for early detection of gastrointestinal diseases, adoption of minimally invasive procedures, and government incentives for advanced medical equipment procurement.
• France: France holds USD 0.09 billion, capturing 4.5% share, with a CAGR of 6.3%, supported by increasing number of specialty hospitals, expanding patient awareness, high adoption rate of advanced endoscopic devices, and rising preference for linear array gastroscopes in interventional gastroenterology procedures.

BY APPLICATION

Hospital: Hospitals represent the largest segment, accounting for over 61% of ultrasound gastroscope usage globally in 2024. This dominance is supported by higher patient volumes, with tertiary hospitals performing up to 4,000 endoscopic ultrasound procedures annually. Hospital-based procurement is often linked to large-scale contracts, with an average order size of 10–15 units per facility.

The Hospital application segment is valued at USD 1.5 billion, capturing 68% market share, with a CAGR of 6.6%, driven by increasing demand for inpatient diagnostic procedures, rising number of gastroenterology units, and growing preference for minimally invasive ultrasound gastroscopes in tertiary care hospitals.

Top 5 Major Dominant Countries in the Hospital Application

• United States: Hospitals in the U.S. contribute USD 0.5 billion, representing 22% share, with a CAGR of 6.7%, fueled by high-end medical facility adoption, growing number of gastrointestinal procedures, strong healthcare infrastructure, and rising integration of advanced endoscopy solutions in hospital networks.
• Germany: Germany holds USD 0.25 billion, capturing 11% share, with a CAGR of 6.5%, driven by large hospital networks, increasing focus on minimally invasive GI diagnostics, rising number of gastroenterology procedures, and government support for advanced healthcare technology procurement.
• Japan: Japanese hospitals account for USD 0.18 billion, representing 8% share, with a CAGR of 6.4%, fueled by growing geriatric patient population, rising prevalence of gastrointestinal disorders, strong technological adoption, and increasing hospital investments in modern endoscopic devices.
• China: Hospitals in China contribute USD 0.16 billion, capturing 7% share, with a CAGR of 6.6%, driven by increasing urban healthcare facilities, government healthcare initiatives, rising GI patient population, and adoption of high-resolution gastroscopy systems.
• France: French hospitals hold USD 0.12 billion, representing 5.5% share, with a CAGR of 6.3%, supported by expansion of hospital networks, increasing gastrointestinal patient base, adoption of minimally invasive endoscopy procedures, and high integration of linear array and optic ultrasound gastroscopes.

Clinic: Clinics hold a 25% market share, primarily in urban centers where specialist gastroenterologists operate. These facilities typically perform 300–800 procedures annually and prefer compact ultrasound gastroscope systems for space efficiency. Adoption in clinics has increased by 19% over the past three years, aided by portable and lower-maintenance models.

The Clinic segment of the Ultrasound Gastroscopes Market is valued at USD 0.9 billion, representing 20% share, with a CAGR of 6.3%, driven by rising outpatient diagnostic procedures, increasing number of specialty clinics, growing preference for minimally invasive gastrointestinal assessments, and adoption of advanced ultrasound gastroscope technology.

Top 5 Major Dominant Countries in the Clinic Application

• United States: The U.S. Clinic segment holds USD 0.35 billion, capturing 7.8% share, with a CAGR of 6.4%, driven by a large network of outpatient centers, increasing patient preference for minimally invasive diagnostics, rising incidence of gastrointestinal disorders, and high adoption of optic and linear array ultrasound gastroscopes.
• Germany: Germany contributes USD 0.2 billion, representing 4.5% share, with a CAGR of 6.2%, supported by advanced outpatient clinic infrastructure, rising prevalence of GI diseases, increasing patient awareness, and the presence of technologically advanced ultrasound gastroscope systems in clinics.
• China: China accounts for USD 0.15 billion, representing 3.3% share, with a CAGR of 6.3%, fueled by expanding clinic networks, rising gastrointestinal diagnostic demand, growing government support for modern healthcare facilities, and high adoption of minimally invasive endoscopy solutions.
• Japan: Japan holds USD 0.12 billion, capturing 2.7% share, with a CAGR of 6.1%, driven by specialized gastroenterology clinics, increasing outpatient endoscopic procedures, rising awareness among patients, and widespread use of both optic and linear array ultrasound gastroscopes.
• India: India contributes USD 0.08 billion, representing 1.8% share, with a CAGR of 6.2%, supported by growing number of private and multi-specialty clinics, increasing gastrointestinal patient population, expanding healthcare expenditure, and rising adoption of minimally invasive diagnostic technologies.

Regional Outlook of the Ultrasound Gastroscopes Market

The ultrasound gastroscopes market exhibits distinct regional adoption trends shaped by healthcare infrastructure, cancer screening programs, and reimbursement systems. North America holds a 39% share due to early technology adoption and robust GI cancer detection programs. Europe follows with 28% market share, supported by national screening initiatives in countries like Germany and France. Asia-Pacific is the fastest-growing region, with 41% of global procedure volumes in 2024, driven by large patient populations and expanding hospital networks.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America leads the global market, accounting for 39% of total ultrasound gastroscope sales in 2024. The U.S. alone conducts over 1.2 million EUS procedures annually, while Canada contributes approximately 150,000. Advanced hospital networks ensure that more than 78% of tertiary care centers are equipped with ultrasound gastroscopes. The adoption of AI-assisted diagnostic modules has grown by 46% over the last three years, enhancing accuracy in tumor detection.

North America dominates the Ultrasound Gastroscopes Market, valued at USD 1.5 billion, with a 34% share, and CAGR of 6.7%, driven by the high adoption of advanced endoscopic technologies, increasing hospital infrastructure, and growing demand for minimally invasive GI diagnostics in the U.S. and Canada.

North America - Major Dominant Countries in the Ultrasound Gastroscopes Market

• United States: The U.S. contributes USD 1.2 billion, representing 28% share, with a CAGR of 6.8%, fueled by high hospital adoption of ultrasound gastroscopes, increasing gastrointestinal patient population, strong R&D in endoscopy technology, and growing focus on minimally invasive diagnostics.
• Canada: Canada holds USD 0.2 billion, capturing 6% share, with a CAGR of 6.5%, driven by rising outpatient clinics, expanding hospital endoscopy units, increasing prevalence of gastrointestinal disorders, and growing adoption of both linear array and optic ultrasound gastroscopes in advanced medical centers.
• Mexico: Mexico accounts for USD 0.05 billion, representing 1.2% share, with a CAGR of 6.4%, supported by increasing healthcare expenditure, rising number of private clinics, expanding gastroenterology units in hospitals, and growing awareness of minimally invasive diagnostic solutions.
• Puerto Rico: Puerto Rico holds USD 0.03 billion, capturing 0.7% share, with a CAGR of 6.3%, fueled by expanding medical tourism, increasing demand for advanced diagnostic procedures, and rising investments in hospitals equipped with state-of-the-art endoscopy devices.
• Cuba: Cuba contributes USD 0.02 billion, representing 0.5% share, with a CAGR of 6.2%, supported by growing number of public healthcare facilities, increased focus on gastrointestinal disease management, and adoption of modern diagnostic endoscopy technologies.

EUROPE

Europe commands a 28% market share, supported by national screening programs and high healthcare expenditure. In 2024, Germany alone performed over 450,000 EUS procedures, followed by France at 320,000 and the U.K. at 250,000. Public healthcare systems in Western Europe cover up to 80% of procedural costs, making advanced gastroscopes widely accessible. More than 65% of hospitals in the EU have integrated ultrasound gastroscope systems into oncology departments.

The European Ultrasound Gastroscopes Market is valued at USD 1 billion, representing 22% share, with a CAGR of 6.5%, driven by increasing hospital and clinic adoption, strong presence of medical device manufacturers, and growing preference for minimally invasive procedures.

Europe - Major Dominant Countries in the Ultrasound Gastroscopes Market

• Germany: Germany leads with USD 0.35 billion, capturing 7% share, with a CAGR of 6.5%, fueled by expanding hospital networks, high adoption of advanced endoscopy devices, strong research initiatives, and growing gastroenterology patient population requiring precise diagnostic solutions.
• France: France holds USD 0.25 billion, representing 5% share, with a CAGR of 6.3%, supported by adoption of both linear array and optic ultrasound gastroscopes, rising prevalence of GI disorders, hospital infrastructure growth, and increasing investments in minimally invasive diagnostics.
• United Kingdom: UK contributes USD 0.2 billion, capturing 4.5% share, with a CAGR of 6.4%, driven by high adoption of advanced imaging technologies, expanding outpatient clinics, rising GI disease prevalence, and government healthcare programs promoting modern endoscopy procedures.
• Italy: Italy accounts for USD 0.12 billion, representing 2.5% share, with a CAGR of 6.3%, fueled by increasing number of hospitals and specialty clinics, rising awareness about gastrointestinal disorders, and growing adoption of both optic and linear array ultrasound gastroscopes.
• Spain holds USD 0.08 billion, capturing 1.5% share, with a CAGR of 6.2%, driven by expanding healthcare facilities, increasing number of gastrointestinal procedures, rising awareness of minimally invasive diagnostics, and growing preference for advanced ultrasound gastroscopes in both hospitals and private clinics.

ASIA-PACIFIC

Asia-Pacific is the most dynamic region, contributing 41% of global ultrasound gastroscope procedures in 2024. China leads with over 1.5 million annual EUS cases, followed by Japan at 900,000 and India at 650,000. Public health policies in China have funded over 1,200 new hospital endoscopy units since 2021. Japan maintains the highest EUS penetration rate globally, with 89% of tertiary care facilities equipped. Technological innovations from local manufacturers in South Korea and Japan have reduced device costs by up to 15%, aiding adoption in Southeast Asia.

The Asia Ultrasound Gastroscopes Market is valued at USD 1.2 billion, accounting for 27% share, with a CAGR of 6.6%, supported by increasing healthcare infrastructure, rising prevalence of gastrointestinal disorders, and growing adoption of advanced endoscopic technologies in countries like China, Japan, and India.

Asia - Major Dominant Countries in the Ultrasound Gastroscopes Market

• China: China contributes USD 0.5 billion, representing 11% share, with a CAGR of 6.7%, fueled by increasing number of tertiary care hospitals, government initiatives to improve GI diagnostics, growing patient awareness, and rising adoption of both linear array and optic ultrasound gastroscopes in urban centers.
• Japan: Japan holds USD 0.35 billion, capturing 8% share, with a CAGR of 6.5%, driven by high prevalence of GI cancers, increasing geriatric population, widespread hospital adoption of advanced endoscopy systems, and strong R&D focus on improving ultrasound gastroscope technology.
• India: India accounts for USD 0.2 billion, representing 4.5% share, with a CAGR of 6.6%, supported by rising healthcare expenditure, expansion of hospitals and clinics, increasing gastrointestinal disease prevalence, and growing preference for minimally invasive diagnostic procedures.
• South Korea: South Korea contributes USD 0.1 billion, capturing 2% share, with a CAGR of 6.4%, fueled by high adoption of advanced imaging technologies, government healthcare support, increasing outpatient diagnostic procedures, and rising investments in ultrasound gastroscope procurement for hospitals.
• Singapore: Singapore holds USD 0.05 billion, representing 1% share, with a CAGR of 6.3%, driven by growing number of specialty medical centers, increasing medical tourism, adoption of state-of-the-art endoscopy equipment, and rising focus on minimally invasive gastrointestinal diagnostics.

MIDDLE EAST & AFRICA

The Middle East & Africa hold a 7% share of the global market, with the UAE, Saudi Arabia, and South Africa as leading adopters. In 2024, the UAE alone invested over USD 120 million in gastroenterology equipment upgrades. Saudi Arabia’s Vision 2030 healthcare strategy includes expanding EUS access to 95% of major hospitals by 2028. South Africa remains the largest market in Sub-Saharan Africa, with 120 hospitals performing regular EUS procedures.

The Middle East and Africa Ultrasound Gastroscopes Market is valued at USD 0.4 billion, accounting for 9% share, with a CAGR of 6.5%, driven by rising investments in healthcare infrastructure, increasing awareness of gastrointestinal disorders, and growing adoption of advanced diagnostic endoscopy technologies.

Middle East and Africa - Major Dominant Countries in the Ultrasound Gastroscopes Market

• Saudi Arabia: Saudi Arabia contributes USD 0.15 billion, representing 3.2% share, with a CAGR of 6.6%, fueled by expanding hospital infrastructure, increasing prevalence of gastrointestinal disorders, government healthcare investments, and rising adoption of advanced optic and linear array ultrasound gastroscopes.
• United Arab Emirates: UAE holds USD 0.1 billion, capturing 2.2% share, with a CAGR of 6.5%, driven by increasing medical tourism, high adoption rate of advanced diagnostic technologies, expanding specialty clinics, and government initiatives supporting minimally invasive procedures.
• South Africa: South Africa accounts for USD 0.07 billion, representing 1.5% share, with a CAGR of 6.4%, supported by rising number of private and public hospitals, increasing awareness of gastrointestinal diagnostics, and adoption of modern ultrasound gastroscope technologies.
• Egypt: Egypt contributes USD 0.05 billion, capturing 1.1% share, with a CAGR of 6.3%, fueled by growing hospital and clinic infrastructure, rising gastrointestinal patient population, increasing healthcare expenditure, and adoption of advanced minimally invasive endoscopic devices.
• Qatar: Qatar holds USD 0.03 billion, representing 0.7% share, with a CAGR of 6.2%, driven by expansion of healthcare facilities, increasing government support for advanced diagnostics, high adoption of modern endoscopy systems, and growing demand for accurate gastrointestinal diagnostic procedures.

List of Top Ultrasound Gastroscopes Companies

• Ethicon Endo-Surgery, LLC
• Stryker Corporation
• Fujifilm Holdings Corporation
• Karl Storz
• Richard Wolf GmbH
• Boston Scientific Corporation
• Olympus Corporation

Ethicon Endo-Surgery, LLC: Ethicon Endo-Surgery, a Johnson & Johnson subsidiary, specializes in advanced endoscopic and surgical equipment, with a strong portfolio in gastroenterology. The company’s ultrasound gastroscopes are integrated with proprietary imaging algorithms that enhance lesion detection accuracy by over 80%. In 2024, Ethicon supplied equipment to over 3,000 hospitals worldwide.

Stryker Corporation: Stryker is recognized for its innovation in medical imaging technologies, offering ultrasound gastroscopes with advanced Doppler capabilities and ergonomic designs. Its systems are used in more than 2,500 healthcare facilities globally. In 2024, Stryker expanded its reach into 14 new international markets, increasing global adoption of its GI imaging solutions by 22%.

Investment Analysis and Opportunities

Investment activity in the ultrasound gastroscopes market is strong, driven by demand for precision diagnostics and expanding screening programs. Over USD 800 million in private equity was directed toward endoscopic ultrasound technologies in 2024. Hospital procurement budgets are prioritizing hybrid imaging platforms, with 57% of new endoscopy units featuring ultrasound capabilities. The Asia-Pacific region presents the most significant opportunity, with over 1,200 hospitals scheduled for EUS upgrades by 2028. Emerging opportunities include portable and AI-enabled systems, with anticipated adoption rates surpassing 40% globally within the next five years.

New Product Development

Innovation in ultrasound gastroscopes is accelerating, with more than 120 patents filed in the past two years. Manufacturers are focusing on AI-assisted image analysis, miniaturized transducers, and enhanced ergonomics. In 2024, over 35% of new product launches featured cloud-based data sharing for remote consultations. Portable ultrasound gastroscopes under 5 kg are enabling usage in ambulatory centers and rural hospitals. Advanced Doppler imaging modules, now present in 42% of newly released devices, have improved vascular mapping accuracy by up to 33%.

Five Recent Developments

• Launch of AI-powered ultrasound gastroscope in Japan with 92% lesion detection accuracy for improved diagnostics.
• FDA clearance for a compact, portable ultrasound gastroscope model in the U.S. market enhancing accessibility.
• Partnership between a South Korean manufacturer and Indian hospitals for EUS training programs and clinical research.
• European pilot program integrating cloud-based EUS image sharing across 12 hospitals for faster diagnostic collaboration.
• Introduction of pediatric-compatible miniaturized ultrasound gastroscope in Germany improving specialized gastroenterology patient care.

Report Coverage of Ultrasound Gastroscopes Market

The ultrasound gastroscopes market report covers product types, applications, regional demand patterns, key players, and technological innovations from 2024 to 2033. The study analyzes over 200 datasets, including hospital procurement rates, cancer screening volumes, and technology adoption trends. Between 2025 and 2030, over 2,000 new hospitals worldwide are projected to integrate EUS technology. By 2033, AI-enhanced ultrasound gastroscopes are expected to account for over 50% of installations. The report includes insights into market opportunities in emerging economies, where adoption rates are increasing by 12–15% annually.

Ultrasound Gastroscopes Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 709.5 Million in 2026
Market Size Value By	USD 1001.08 Million by 2035
Growth Rate	CAGR of 3.9% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Optic Ultrasound Gastroscope Linear Array Ultrasound Gastroscope By Application : Hospital Clinic Medical Center Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample